Deutsche Bank’s Virtus Biotech ETF BBP Stock Holding History

Deutsche Bank’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-75,000	Closed	-$1.96M	–	5136
2014 Q4	$1.96M	Buy	+75,000	New	+$1.96M	﹤0.01%	2684

Other funds holding BBP

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Deutsche Bank's BBP Position: Q1 2015 in Review

Deutsche Bank sold out of Virtus Biotech ETF (BBP) in Q1 2015, closing a stake of 75,000 shares — an estimated $1.96M sold.

Deutsche Bank first reported a position in BBP in Q4 2014 and held it in 1 quarter. The position peaked at $1.96M in Q4 2014. 7 funds tracked by Wall St. Rank hold BBP as of Q1 2015.

Deutsche Bank reported no remaining Virtus Biotech ETF position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 75,000 Virtus Biotech ETF shares in Q1 2015, an estimated $1.96M.
Deutsche Bank first reported a position in Virtus Biotech ETF in Q4 2014 and held it in 1 quarter.
Deutsche Bank's Virtus Biotech ETF position peaked at $1.96M in Q4 2014.
7 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.